Myeloproliferative diseases

No definition available.

Endpoint definition

↥
FinnGen phenotype data

Filter registries None

Check pre-conditions None

Check conditions None

Apply sex-specific rule None

diagram downward connector MYELOPROF

Extra metadata

First used in FinnGen datafreeze DF2, additional

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 1083 579 504
Unadjusted prevalence (%) 0.42 0.39 0.45
Mean age at first event (years) 60.01 59.32 60.79

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.06 3.99 [2.59, 6.16] 3.8e-10 173
15 years 0.03 4.20 [2.75, 6.40] 2.5e-11 161
5 years 0.01 6.79 [4.76, 9.68] 3.9e-26 86
1 year - - - -

Correlations

↥

Index endpoint: MYELOPROF – Myeloproliferative diseases
GWS hits: 7

Survival analyses between endpoints

↥

Plot

before Myeloproliferative diseases
after Myeloproliferative diseases

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Myeloproliferative diseases

↥